Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.

Sand M, Skrygan M, Georgas D, Sand D, Gambichler T, Altmeyer P, Bechara FG.

Cell Tissue Res. 2012 Oct;350(1):119-26. doi: 10.1007/s00441-012-1446-0. Epub 2012 Jun 17.

PMID:
22706980
2.

Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.

Sand M, Skrygan M, Sand D, Georgas D, Gambichler T, Hahn SA, Altmeyer P, Bechara FG.

Cell Tissue Res. 2013 Jan;351(1):85-98. doi: 10.1007/s00441-012-1514-5. Epub 2012 Oct 31.

PMID:
23111773
3.

Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer.

Sand M, Skrygan M, Georgas D, Arenz C, Gambichler T, Sand D, Altmeyer P, Bechara FG.

Mol Carcinog. 2012 Nov;51(11):916-22. doi: 10.1002/mc.20861. Epub 2011 Oct 24.

PMID:
22025453
4.

Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi.

Sand M, Gambichler T, Sand D, Altmeyer P, Stuecker M, Bechara FG.

Eur J Dermatol. 2011 Jan-Feb;21(1):18-21. doi: 10.1684/ejd.2011.1210.

PMID:
21262599
5.

Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer.

Sand M, Gambichler T, Skrygan M, Sand D, Scola N, Altmeyer P, Bechara FG.

Cancer Invest. 2010 Jul;28(6):649-53. doi: 10.3109/07357901003630918.

PMID:
20210522
6.

Signatures of microRNAs and selected microRNA target genes in human melanoma.

Philippidou D, Schmitt M, Moser D, Margue C, Nazarov PV, Muller A, Vallar L, Nashan D, Behrmann I, Kreis S.

Cancer Res. 2010 May 15;70(10):4163-73. doi: 10.1158/0008-5472.CAN-09-4512. Epub 2010 May 4.

7.
8.

Patterns of melastatin mRNA expression in melanocytic tumors.

Deeds J, Cronin F, Duncan LM.

Hum Pathol. 2000 Nov;31(11):1346-56.

PMID:
11112208
9.

Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis.

Kaddu S, Smolle J, Zenahlik P, Hofmann-Wellenhof R, Kerl H.

Melanoma Res. 2002 Jun;12(3):271-8.

PMID:
12140384
10.

Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours.

Miracco C, De Nisi MC, Arcuri F, Cosci E, Pacenti L, Toscano M, Lalinga AV, Biagioli M, Rubegni P, Vatti R, Maellaro E, Del Bello B, Massi D, Luzi P, Tosi P.

Int J Oncol. 2006 Feb;28(2):345-52.

PMID:
16391788
11.

BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin.

Uribe P, Wistuba II, González S.

Am J Dermatopathol. 2003 Oct;25(5):365-70.

PMID:
14501284
12.
13.

Melanoma antigen-encoding gene expression in melanocytic naevi and cutaneous malignant melanomas.

Basarab T, Picard JK, Simpson E, Russell-Jones R.

Br J Dermatol. 1999 Jan;140(1):106-8.

PMID:
10215777
14.

Reduced Expression of RECK Protein May Help Differentiate Cutaneous Malignant Melanoma from Melanocytic Nevus.

Zhang L, Xie Q, Shan SJ, Tabor MK, Junkins-Hopkins JM.

Anticancer Res. 2015 Jun;35(6):3185-91. Erratum in: Anticancer Res. 2015 Jul;35(7):4371.

PMID:
26026078
15.

Staining of melanocytic neoplasms by melanoma antigen recognized by T cells.

Mehregan DR, Hamzavi I.

Am J Dermatopathol. 2000 Jun;22(3):247-50.

PMID:
10871068
16.

Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases.

Kraehn GM, Utikal J, Udart M, Greulich KM, Bezold G, Kaskel P, Leiter U, Peter RU.

Br J Cancer. 2001 Jan 5;84(1):72-9.

17.

Frequent downregulation of Fas (CD95) expression and function in melanoma.

Bullani RR, Wehrli P, Viard-Leveugle I, Rimoldi D, Cerottini JC, Saurat JH, Tschopp J, French LE.

Melanoma Res. 2002 Jun;12(3):263-70.

PMID:
12140383
19.

Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.

Boyd AS, Shakhtour B, Shyr Y.

J Am Acad Dermatol. 2008 May;58(5):750-4. doi: 10.1016/j.jaad.2007.12.026. Epub 2008 Feb 4.

PMID:
18249467
20.

Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.

Massi D, Franchi A, Sardi I, Magnelli L, Paglierani M, Borgognoni L, Maria Reali U, Santucci M.

J Pathol. 2001 Jun;194(2):194-200.

PMID:
11400148

Supplemental Content

Support Center